← Back to ADPT

Adaptive Biotechnologies Corporation - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/08/2025Mar 2024Filed 01/05/2025
$72$71$94$59$52$46$43$42
−$40−$20$9.5−$26−$30−$32−$46−$48
−$0.25−$0.13$0.06−$0.17−$0.20−$0.22−$0.31−$0.33
160156163152149148147146

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.